4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-002096
Options or other derivatives
- Chief Executive Officer acquired 16,467 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Climaco John M · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-29 | Grant or award : show line 1 in the form Restricted Stock Units | +16,467 | 61,451 | D |
Loading xslF345X04/ownership.xml…